XML 21 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Assets    
Securities available-for-sale, amortized cost $ 2,270,709 $ 3,256,289
Securities available-for-sale, allowance for credit Losses (ACL) 0 0
Securities held to maturity, net of ACL 0 0
Securities held to maturity, fair value $ 1,406,589 $ 353,511
Shareholders' Equity    
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, authorized (in shares) 250,000,000 250,000,000
Common stock, issued (in shares) 60,977,686 61,648,679
Common stock, outstanding (in shares) 60,977,686 61,648,679